Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Myrna R. Nahas & David Avigan. (2016) Challenges in vaccine therapy in hematological malignancies and strategies to overcome them. Expert Opinion on Biological Therapy 16:9, pages 1093-1104.
Read now
Read now
Maša Kandušer & Marko Ušaj. (2014) Cell electrofusion: past and future perspectives for antibody production and cancer cell vaccines. Expert Opinion on Drug Delivery 11:12, pages 1885-1898.
Read now
Read now
Jacalyn Rosenblatt, Michal Bar-Natan, Nikhil C Munshi & David E Avigan. (2014) Immunotherapy for multiple myeloma. Expert Review of Hematology 7:1, pages 91-96.
Read now
Read now
Shifang Yuan, Changhong Shi, Li Liu & Wei Han. (2010) MUC1-based recombinant Bacillus Calmette–Guerin vaccines as candidates for breast cancer immunotherapy. Expert Opinion on Biological Therapy 10:7, pages 1037-1048.
Read now
Read now
Choon-Kit Tang & Vasso Apostolopoulos. (2008) Strategies used for MUC1 immunotherapy: preclinical studies. Expert Review of Vaccines 7:7, pages 951-962.
Read now
Read now
Articles from other publishers (35)
Simon Hawlina, Robert Zorec & Helena H. Chowdhury. (2023) Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer. Life 13:7, pages 1498.
Crossref
Crossref
Mengfei Chen. (2023) Development of cell-based vaccines in cancer treatment. Highlights in Science, Engineering and Technology 36, pages 1342-1346.
Crossref
Crossref
Naotomo Tottori, Sora Sadamichi, Shinya Sakuma, Tomomi Tsubouchi & Yoko Yamanishi. (2022) On-chip Continuous Pairing, Separation and Electrofusion of Cells Using a Microdroplet. On-chip Continuous Pairing, Separation and Electrofusion of Cells Using a Microdroplet.
Julia Belansky & Dvir Yelin. (2022) Optimization study of plasmonic cell fusion. Scientific Reports 12:1.
Crossref
Crossref
Xiufang Liu, Wenjun Zhang, Umar Farooq, Ning Rong, Jingyao Shi, Na Pang, Lisheng Xu, Lili Niu & Long Meng. (2022) Rapid cell pairing and fusion based on oscillating bubbles within an acoustofluidic device. Lab on a Chip 22:5, pages 921-927.
Crossref
Crossref
Simon Hawlina, Helena H. Chowdhury, Tomaž Smrkolj & Robert Zorec. (2022) Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number. Biology Direct 17:1.
Crossref
Crossref
Xuan Mu & Yu Shrike Zhang. 2022. Engineering Technologies and Clinical Translation. Engineering Technologies and Clinical Translation
155
195
.
Gaurav Pendharkar, Yen-Ta Lu, Chia-Ming Chang, Meng-Ping Lu, Chung-Huan Lu, Chih-Chen Chen & Cheng-Hsien Liu. (2021) A Microfluidic Flip-Chip Combining Hydrodynamic Trapping and Gravitational Sedimentation for Cell Pairing and Fusion. Cells 10:11, pages 2855.
Crossref
Crossref
Bart Geboers, Hester J. Scheffer, Philip M. Graybill, Alette H. Ruarus, Sanne Nieuwenhuizen, Robbert S. Puijk, Petrousjka M. van den Tol, Rafael V. Davalos, Boris Rubinsky, Tanja D. de Gruijl, Damijan Miklavčič & Martijn R. Meijerink. (2020) High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy. Radiology 295:2, pages 254-272.
Crossref
Crossref
Weihua He, Liang Huang, Yongxiang Feng, Fei Liang, Wei Ding & Wenhui Wang. (2019) Highly integrated microfluidic device for cell pairing, fusion and culture. Biomicrofluidics 13:5.
Crossref
Crossref
Myrna R. Nahas, Dina Stroopinsky, Jacalyn Rosenblatt, Leandra Cole, Athalia R. Pyzer, Eleni Anastasiadou, Anna Sergeeva, Adam Ephraim, Abigail Washington, Shira Orr, Malgorzata McMasters, Matthew Weinstock, Salvia Jain, Rebecca K. Leaf, Haider Ghiasuddin, Maryam Rahimian, Jessica Liegel, Jeffrey J. Molldrem, Frank Slack, Donald Kufe & David Avigan. (2019) Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine. British Journal of Haematology 185:4, pages 679-690.
Crossref
Crossref
Myrna R. Nahas, Jacalyn Rosenblatt, Hillard M. Lazarus & David Avigan. (2018) Anti-cancer vaccine therapy for hematologic malignancies: An evolving era. Blood Reviews 32:4, pages 312-325.
Crossref
Crossref
Jeffery Schlom, James L. Gulley & James W. Hodge. 2016. Holland-Frei Cancer Medicine. Holland-Frei Cancer Medicine
1
22
.
Yen-Ta Lu, Gaurav Prashant Pendharkar, Chung-Huan Lu, Chia-Ming Chang & Cheng-Hsien Liu. (2015) A microfluidic approach towards hybridoma generation for cancer immunotherapy. Oncotarget 6:36, pages 38764-38776.
Crossref
Crossref
Gaurav Pendharkar, Chung-Huan Lu, Yen-Ta Lu, Aming Chang & Cheng-Hsien Liu. (2015) Microfluidic chip for rapid electrofusion of homogeneous and heterogeneous cells. Microfluidic chip for rapid electrofusion of homogeneous and heterogeneous cells.
Michal Bar-Natan, Kenneth C. Anderson & David E. Avigan. 2015. Cancer Immunology. Cancer Immunology
69
91
.
Burak Dura, Yaoping Liu & Joel Voldman. (2014) Deformability-based microfluidic cell pairing and fusion. Lab on a Chip 14:15, pages 2783.
Crossref
Crossref
Maria A Garcia-MarquezAlexander Shimabukuro-Vornhagen, Sebastian Theurich & Michael von Bergwelt-Baildon. (2013) Vaccination with dendritic cell–tumor fusion cells in multiple myeloma patients: a promising strategy?. Immunotherapy 5:10, pages 1039-1042.
Crossref
Crossref
Jon Arnason & David Avigan. (2012) Evolution of cellular immunotherapy: from allogeneic transplant to dendritic cell vaccination as treatment for multiple myeloma. Immunotherapy 4:10, pages 1043-1051.
Crossref
Crossref
David Avigan, Jacalyn Rosenblatt & Donald Kufe. (2012) Dendritic/Tumor Fusion Cells as Cancer Vaccines. Seminars in Oncology 39:3, pages 287-295.
Crossref
Crossref
Michael Dougan & Glenn Dranoff. 2012. Innate Immune Regulation and Cancer Immunotherapy. Innate Immune Regulation and Cancer Immunotherapy
391
414
.
Wenxue Ma, Trevor Smith, Vladimir Bogin, Yu Zhang, Cengiz Ozkan, Mihri Ozkan, Melanie Hayden, Stephanie Schroter, Ewa Carrier, Davorka Messmer, Vipin Kumar & Boris Minev. (2011) Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy. Journal of Translational Medicine 9:1.
Crossref
Crossref
Katerina Skalova, Klara Mollova & Jaroslav Michalek. (2010) Human myeloid dendritic cells for cancer therapy: Does maturation matter?. Vaccine 28:32, pages 5153-5160.
Crossref
Crossref
Jing-Yue Yang, Da-Yong Cao, Long-Yang Ma & Wen-Chao Liu. (2010) Dendritic cells fused with allogeneic hepatocellular carcinoma cell line compared with fused autologous tumor cells as hepatocellular carcinoma vaccines. Hepatology Research 40:5, pages 505-513.
Crossref
Crossref
Jing Ni, Britta Nolte, Annette Arnold, Philippe Fournier & Volker Schirrmacher. (2009) Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence. Vaccine 27:40, pages 5480-5487.
Crossref
Crossref
Mateja Gabrijel, Martina Bergant, Marko Kreft, Matjaž Jeras & Robert Zorec. (2009) Fused Late Endocytic Compartments and Immunostimulatory Capacity of Dendritic–Tumor Cell Hybridomas. Journal of Membrane Biology 229:1, pages 11-18.
Crossref
Crossref
Michael DouganGlenn Dranoff. (2009) Immune Therapy for Cancer. Annual Review of Immunology 27:1, pages 83-117.
Crossref
Crossref
Nisreen Al-Shaibi & Swapan K. Ghosh. (2009) A novel cell-surface protein CSP82 on bone marrow stem cells and a cytosolic phosphoprotein DP58 (ankyrinRD 34B) are involved in promyeloid progenitor induction. Cellular Immunology 258:2, pages 172-180.
Crossref
Crossref
Thomas Dittmar, Christa Nagler, Sarah Schwitalla, Kathrin Krause, Jeanette Seidel, Georg Reith, Bernd Niggemann & Kurt S. Zänker. 2010. Stem Cell Biology in Health and Disease. Stem Cell Biology in Health and Disease
327
356
.
Dev Karan, Arthur M. Krieg & David M. Lubaroff. (2007) Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine. International Journal of Cancer 121:7, pages 1520-1528.
Crossref
Crossref
Sandra Tuyaerts, Joeri L. Aerts, Jurgen Corthals, Bart Neyns, Carlo Heirman, Karine Breckpot, Kris Thielemans & Aude Bonehill. (2007) Current approaches in dendritic cell generation and future implications for cancer immunotherapy. Cancer Immunology, Immunotherapy 56:10, pages 1513-1537.
Crossref
Crossref
Huang-Ge Zhang, Helen Kim, Cunren Liu, Shaohua Yu, Jianhua Wang, William E. Grizzle, Robert P. Kimberly & Stephen Barnes. (2007) Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1773:7, pages 1116-1123.
Crossref
Crossref
Barbara-ann Guinn, Noriyuki Kasahara, Farzin Farzaneh, Nagy A Habib, James S Norris & Albert B Deisseroth. (2007) Recent Advances and Current Challenges in Tumor Immunology and Immunotherapy. Molecular Therapy 15:6, pages 1065-1071.
Crossref
Crossref
Barbara-ann Guinn, Noriyuki Kasahara, Farzin Farzaneh, Nagy A Habib, James S Norris & Albert B Deisseroth. (2007) Recent Advances and Current Challenges in Tumor Immunology and Immunotherapy. Molecular Therapy.
Crossref
Crossref
Janina Schaper, Hermann Richard Bohnenkamp & Thomas Noll. 2007. Cell Technology for Cell Products. Cell Technology for Cell Products
207
216
.